Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Aglaia odorata" patented technology

Aglaia odorata is a species of plant in the family Meliaceae. It is found in Cambodia, China, Indonesia, Myanmar, Taiwan, Thailand, Vietnam, and possibly Laos. It is occasionally sold as a house plant under the name "Chinese perfume plant." It can be grown outdoors in USDA zones 9 and 10.

Endophytic fungi of orange-yellow phoenix flower and application thereof

The invention provides an endophytic fungus of citrus aurantium, the endophytic fungus of citrus aurantium is classified and named as Fusarium sp., the endophytic fungus of citrus aurantium is preserved in Guangdong Microbial Culture Collection Center on October 21, 2025, and the preservation number of the strain is GDMCC No.67138. The endophytic fungus of citrus aurantium has the advantages that the endophytic fungus of citrus aurantium is named as Fusarium sp. The endophytic fungi of the orange yellow phoenix flower can promote the growth rate of anoectochilus formosanus seedlings.
Owner:HUIZHOU UNIV

A detection and identification kit, method and application of aglaia odorata

The present application belongs to the technical field of plant species identification, and particularly relates to a detection and identification kit, method and application of Aglaia odorata. The kit contains an upstream primer with a nucleotide sequence of SEQ ID NO. 1, a downstream primer with a nucleotide sequence of SEQ ID NO. 2, and a restriction enzyme Sma I. The primer is used for PCR amplification of sample DNA, and the amplification product is digested by a restriction enzyme Sma I. The enzyme-digested product is subjected to agarose gel electrophoresis, and according to the number and size of specific electrophoretic bands, Aglaia odorata and its similar species can be distinguished and identified conveniently and quickly. The method has the advantages of intuitive results, high specificity, high identification efficiency, and avoidance of false positive amplification.
Owner:HAINAN ENTRY-EXIT INSPECTION & QUARANTINE BUREAU TROPICAL PLANT ISOLATION & QUARANTINE CENT

Streptomyces griseoviridis AH001 isolated from aglaia odorata and application thereof

PendingCN122256172ABiocideBacteriaBiotechnologyStreptomyces griseoviridis
This invention belongs to the field of microbial technology, specifically relating to a strain of *Streptomyces gracilis* AH001 isolated from *Anthurium stenoptera* and its applications. *Streptomyces gracilis* (… Streptomyces pratensis Streptomyces AH001 was deposited at the Guangdong Provincial Microbial Culture Collection Center on January 14, 2026, with accession number GDMCC No. 67655. Indoor experiments have shown that Streptomyces AH001 has a significant inhibitory effect on various pathogens originating from Anthurium andraeanum, and can be used to prepare highly effective microbial biocontrol agents to ensure biological and environmental safety while controlling Anthurium andraeanum diseases.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

Flavaglines compounds as well as preparation method and application thereof

The invention relates to a Flavaglines compound as well as a preparation method and application thereof, in particular to a Flavaglines compound extracted from Aglaia indica and a preparation method and application thereof, and belongs to the technical field of medicines. The invention provides a method for preparing and identifying 15 new flavaglines derivatives by taking branches and leaves, especially dry branches and leaves, of Aglaia Bilutea L. as raw materials for the first time, systematically evaluates the activity of the flavaglines in the aspect of neuroprotection, and provides a new method for preparing and identifying the 15 new flavaglines derivatives in the aspect of neuroprotection, so that the new flavaglines derivatives can be used for preparing and identifying the new flavaglines derivatives in the aspect of neuroprotection, and the new flavaglines can be used for preparing and identifying the new flavaglines in the aspect of neuroprotection in the aspect of neuroprotection in the aspect of neuroprotection. The invention illustrates the application of the compound in the aspect of developing and treating the neurodegenerative diseases.
Owner:SHENYANG PHARMA UNIV